Andreas Kiesbye Øvlisen

Medicine and Dentistry

1. Patient 100%
2. Therapeutic Procedure 33%
3. Lymphoma 26%
4. Non-Hodgkin Lymphoma 25%
5. Cohort Analysis 24%
6. Hodgkin's Lymphoma 22%
7. Diffuse Large B-Cell Lymphoma 21%
8. Spontaneous Remission 20%
9. Psychoactive Drug 19%
10. Adult 17%
11. Drug Megadose 16%
12. Acute Myeloid Leukemia 15%
13. Methotrexate 15%
14. Prophylaxis 15%
15. B-Cell Lymphoma 15%
16. Drug Use 15%
17. Diagnosis 13%
18. Inpatient 12%
19. Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine 11%
20. Analysis 11%
21. Overall Survival 10%
22. Assisted Reproductive Technology 8%
23. Cancer 8%
24. Prognosis 8%
25. Age 8%
26. Childbirth 8%
27. Anxiety 7%
28. Burkitt's Lymphoma 7%
29. Systematic Review 7%
30. Health Care 7%
31. Osteoporosis 7%
32. Steroid 7%
33. Diabetes 7%
34. Clinical Trial 7%
35. Somatics 7%
36. Loss of Function Mutation 7%
37. Diabetes Mellitus 7%
38. Eosinophilic Esophagitis 7%
39. Central Nervous System 7%
40. Diseases 7%
41. Hazard Ratio 7%
42. Follow up 6%
43. Follicular Lymphoma 5%
44. Male 5%
45. Female 5%
46. Myeloproliferative Neoplasm 5%